Ardelyx (ARDX) EBITDA Margin Growth (3y) (2018 - 2026)
Ardelyx (ARDX) EBITDA Margin Growth (3y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-40,178.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
530.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Ardelyx |
1.49 Bn |
1.25 Bn |
89.66 Mn |
19,505.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
19,505.00 |
| Dec 31, 2025 |
-2,461.00 |
| Sep 30, 2025 |
43,551.00 |
| Jun 30, 2025 |
104,767.00 |
| Mar 31, 2025 |
596,003.00 |
| Dec 31, 2024 |
352,605.00 |
| Sep 30, 2024 |
371,541.00 |
| Jun 30, 2024 |
341,824.00 |
| Mar 31, 2024 |
44,562.00 |
| Dec 31, 2023 |
151,886.00 |
| Sep 30, 2023 |
68,759.00 |
| Jun 30, 2023 |
126,208.00 |
| Mar 31, 2023 |
161,452.00 |
| Dec 31, 2022 |
90,319.00 |
| Sep 30, 2022 |
32,240.00 |
| Jun 30, 2022 |
14.04 Mn |
| Dec 31, 2021 |
2.93 Mn |
| Sep 30, 2021 |
1.03 Mn |
| Jun 30, 2021 |
7.07 Mn |
| Mar 31, 2021 |
23,171.00 |
